NCT05120908 is a clinical trial in Discrimination, Racial, sponsored by University of California, Los Angeles.

Who is sponsoring NCT05120908?

NCT05120908 is sponsored by University of California, Los Angeles.

What condition does NCT05120908 study?

NCT05120908 studies Discrimination, Racial, Social Isolation, Stress.

Is NCT05120908 still recruiting?

NCT05120908 is currently completed. Last updated 10 January 2025.

Last reviewed 2025-01-10 · How we verify

NCT05120908

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Discrimination and the Brain-Gut-Microbiome (BGM) Axis

Completed Last updated 10 January 2025

What this trial tests

trial in Discrimination, Racial in 266 participants. Completed in 31 December 2024.

Timeline

24 August 2021

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University of California, Los Angeles
Status	Completed
Study type	OBSERVATIONAL
Enrollment	266
Start date	24 August 2021
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Conditions studied

Discrimination, Racial — all drugs for Discrimination, Racial →
Social Isolation — all drugs for Social Isolation →
Stress — all drugs for Stress →

Sponsor

University of California, Los Angeles

Who can join

Adults 18 to 50, female only, with Discrimination, Racial or Social Isolation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obesity is a major public health problem related to a variety of illnesses such as heart disease and diabetes. Prior research indicates that social stressors contribute to risk for obesity, possibly through alterations in diet and physical activity. However, it is not fully clear how these alterations contribute to obesity. The purpose of this study is to examine how the stressors of social isolation and discrimination relate to eating behaviors and dietary patterns, and further, how these behaviors affect the brain-gut-microbiome (BGM) connections. This study will focus on Mexican and Filipina women because research shows that they encounter a high burden of obesity and exposure to social stressors. Approximately 300 Mexican and Filipina women will be screened and enrolled. They will then provide information about social stressors via food diaries, physical body measures (e.g. waist circumference), questionnaire data regarding diet and eating behaviors, and measures of physical activity. Stool and serum will be collected to analyze microbes and metabolomics, and MRI to assess brain changes in the reward network. Analytic techniques will be used to integrate data from these multiple data sources. This analysis will determine the unique differences associated with ethnicity and social stressors in moderating eating behaviors and dietary patterns. The results of this study will provide new information about a possible pathway whereby social stressors affect behavioral, neurological and microbiome mechanisms related to obesity risk and provide new information in BGM patterns in two understudied ethnic groups. In the long term, this research may suggest possible approaches for intervention that may help reduce inequalities in obesity and related health problems.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mediation of the association between disadvantaged neighborhoods and cortical microstructure by body mass index.
Kilpatrick LA, Zhang K, Dong TS, Gee GC, et al · · 2023 · cited 2× · PMID 37714947 · DOI 10.1038/s43856-023-00350-5

Verify or expand the search:

Other recruiting trials for Discrimination, Racial

Currently open trials in the same condition.

NCT05552053 — Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women · Phase 2, PHASE3 · active not recruiting
NCT05723081 — Oklahoma Study of Native American Pain Risk III: Stress and Resilience · recruiting
NCT05490927 — Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults · NA · recruiting

Other University of California, Los Angeles trials

Trials by the same sponsor.

NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05120908 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 10 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05120908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing